AVASTIN conc perf 100 mg/4 ml flac 4 ml
7680569220014
CH-56922
L01FG01
07.16.1.
Reimbursement limitations:
AVASTIN.01
Carcinome colorectal
Après accord sur la prise en charge des frais par l’assureur-maladie après consultation …
1 / 2
google
Details
- Product number
- 5692201
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- bevacizumabum 100 mg, trehalosum dihydricum, natrii dihydrogenophosphas monohydricus, dinatrii phosphas, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 4 ml corresp. natrium 5.416 mg.
Articles (1)
Avastin 100 mg/4 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
5.416 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 322.95
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
15/01/2005
Authorization holder
Roche Pharma (Schweiz) AG
4058 Basel
Authorization information
- Swissmedic authorization number
- 56922
- Drug name
- Avastin, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOPA
- ATC Code
- L01FG01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 16/12/2004
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- AVASTIN conc perf 100 mg/4 ml flac 4 ml
- Description (DE)
- AVASTIN Inf Konz 100 mg/4 ml Durchstf 4 ml
- Market launch
- 16/12/2004
- Narcotic (BTM)
- No